Recruiting Sickle Cell Disease Studies in Aurora
About Sickle Cell Disease Clinical Trials in Aurora
Sickle cell disease is a group of inherited blood disorders where abnormal hemoglobin causes red blood cells to become rigid and sickle-shaped. It causes pain crises, organ damage, and shortened life expectancy. Treatment includes hydroxyurea, blood transfusions, and gene therapy.
There are currently 2 sickle cell disease clinical trials recruiting participants in Aurora, CO. These studies are seeking a combined 534 participants. Research is being sponsored by Novo Nordisk A/S, Arkansas Children's Hospital Research Institute. Clinical trial participation is free and participants receive study-related medical care at no cost.
Sickle Cell Disease Clinical Trials in Aurora — FAQ
Are there sickle cell disease clinical trials in Aurora?
Yes, there are 2 sickle cell disease clinical trials currently recruiting in Aurora, CO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Aurora?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.
Are clinical trials in Aurora free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.
What sickle cell disease treatments are being tested?
The 2 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for sickle cell disease.
Data updated October 12, 2026 from ClinicalTrials.gov